Multiple Choice

Urban beekeeping — the practice of keeping honey bee colonies in cities — has expanded rapidly in many Western countries since the early 2000s. Advocates argue that city bees help pollinate urban gardens and green spaces, boosting plant biodiversity in areas often characterised by dense concrete and limited vegetation. Studies conducted in London, Berlin, and New York have consistently reported that rooftop hives produce commercially viable honey yields, suggesting that cities can support healthy colonies despite lacking traditional agricultural landscapes.

Critics, however, warn that the enthusiasm for urban beekeeping may be causing unforeseen ecological harm. The main concern centres on competition: managed honey bees introduced into cities compete directly for limited nectar and pollen resources with wild pollinators such as bumblebees, solitary bees, and hoverflies. A 2019 study published in the journal Insect Conservation and Diversity found that at sites where honey bee density was high, the abundance and diversity of wild bee species declined significantly within a 500-metre radius. The researchers concluded that the net effect of high-density urban beekeeping could be negative for overall pollinator communities.

Proponents of urban beekeeping counter these findings by highlighting differences in research methodology. They point out that the 2019 study measured only a small number of urban sites over a single season, making it difficult to draw broad conclusions. Moreover, they argue that responsible beekeeping practices — limiting hive density, planting diverse forage, and monitoring wild pollinator populations — can mitigate competitive pressure. Several cities, including Brussels and Oslo, have introduced voluntary registration schemes that encourage keepers to space hives at least one kilometre apart.

The debate has prompted municipal authorities to examine the evidence more carefully before endorsing or restricting urban beekeeping. Some cities have opted to cap the number of registered hives per square kilometre, while others have invested in habitat creation projects designed to expand the total forage available to all pollinator species. Conservationists generally agree that increasing flowering plant cover in cities is a more reliable strategy for supporting pollinator health than simply adding more hives, though they acknowledge that well-managed urban apiaries can serve an important educational role.

What remains clear is that urban beekeeping sits at the intersection of ecological science, public enthusiasm, and municipal policy — a combination that makes definitive, universally applicable conclusions elusive. Further longitudinal studies across a wider range of cities will be required before urban beekeeping can be declared unambiguously beneficial or harmful. Until then, practitioners and policymakers alike are advised to err on the side of caution.

For centuries, sailors who ventured beyond sight of land faced a deceptively simple problem with no reliable solution: determining their exact position on the open ocean. Latitude — the distance north or south of the equator — could be calculated with reasonable accuracy by measuring the angle of the sun at noon or the height of the Pole Star above the horizon. Longitude, however, the east–west coordinate, proved far more elusive. Because the Earth rotates, establishing longitude requires an accurate comparison between local time, which can be read from the position of the sun, and the time at a fixed reference point, such as a home port. A discrepancy of only a few minutes could place a ship dozens of miles from its true position.

The consequences of this uncertainty were frequently catastrophic. In 1707, a British naval fleet returning from Gibraltar miscalculated its longitude and struck rocks off the Isles of Scilly, costing nearly two thousand lives. The disaster galvanised public opinion, and in 1714 the British Parliament passed the Longitude Act, offering a cash prize — equivalent to several million pounds today — to anyone who could devise a practical method of determining longitude at sea. Most scientists of the period assumed that the solution would come from astronomy, by mapping the predictable motion of the moon against the background stars.

It was a self-taught clockmaker named John Harrison who ultimately triumphed, though not through astronomy. Harrison reasoned that if a clock could keep accurate time aboard a rolling, temperature-varying ship, a navigator could simply compare it with local noon to calculate longitude directly. Existing pendulum clocks were useless at sea, as the constant motion of the ship disrupted their mechanism. Over four decades, Harrison built a series of increasingly refined timepieces, culminating in a compact device, now known as H4, that lost only a few seconds during a long voyage to Jamaica in 1761.

Harrison's achievement was not immediately rewarded. The board administering the prize was dominated by astronomers who favoured the lunar-distance method and were reluctant to credit a mechanical solution devised by an outsider. Harrison received partial payments but was forced to petition the King before he was finally granted the bulk of the money, by which time he was an old man. Nevertheless, the marine chronometer he pioneered transformed navigation. Within decades, accurate timepieces had become standard equipment, dramatically reducing shipwrecks and enabling the precise charting of coastlines that underpinned the expansion of global trade.

Historians today regard the longitude problem as a landmark example of how a practical challenge can drive innovation in unexpected directions. The eventual answer came not from the prestigious science of astronomy but from precision engineering — a reminder that the most influential breakthroughs are not always those that contemporary experts anticipate.

The placebo effect — a measurable improvement in a patient's condition following a treatment that contains no active therapeutic ingredient — has long puzzled medical researchers. A patient given a sugar pill, but told it is a powerful painkiller, frequently reports genuine relief. For much of the twentieth century, such responses were dismissed as evidence that the original complaint had been imaginary. More recent research, however, suggests that the placebo effect reflects real physiological changes in the brain and body, triggered not by the inert substance itself but by the patient's expectation of recovery.

Studies using brain imaging have shown that when patients anticipate pain relief, the brain releases endorphins — naturally occurring chemicals that act on the same receptors as opioid drugs. In one revealing experiment, the effect of a placebo painkiller could be abolished by administering a second drug that blocks opioid receptors, strongly implying that the relief had been biochemically produced rather than merely reported. The strength of the response appears to depend heavily on context: the colour and size of a pill, the confidence of the prescribing doctor, and even the apparent price of the treatment can all influence how effective a placebo proves to be.

Intriguingly, the placebo effect does not always require deception. In a series of trials, patients with chronic conditions who were openly told that their pills contained no medication nonetheless reported significant improvement, provided that the reasoning behind the treatment was explained to them sympathetically. This finding challenges the long-held assumption that a placebo works only when the patient is misled, and it has opened the possibility of prescribing so-called 'honest placebos' in clinical practice without raising the usual ethical objections.

Not all conditions respond equally. Placebos can reduce symptoms that are shaped by the brain's interpretation of signals — pain, nausea, fatigue, and anxiety — but they cannot shrink a tumour or eliminate an infection. This distinction is critical: a placebo may make a patient feel better without altering the underlying disease at all. Critics warn that uncritical enthusiasm for placebos could lead patients to forgo genuinely effective treatment, a particular danger when alternative therapies that lack any active ingredient are marketed as cures.

The placebo effect also has a lesser-known counterpart, the nocebo effect, in which negative expectations produce harmful outcomes. Patients warned in detail of a drug's possible side effects, for instance, are more likely to experience those very symptoms, even when they have in fact been given a dummy pill. Taken together, these phenomena underline a conclusion that medicine has been slow to embrace: the mind's expectations are not a distraction from the body's response to treatment but an integral component of it.